Skip to content
  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube
ERN-RND | European Reference Network on Rare Neurological Diseases

ERN-RND | European Reference Network on Rare Neurological Diseases

for rare or low prevalence complex diseases

Members Area
  • Home
  • About us
    • What is an ERN
    • Cross border healthcare
    • What is ERN-RND
    • Objectives of ERN-RND
    • Diseases Groups Covered
    • ERN-RND coordinators
    • ERN-RND coordination office
    • ERN-RND board
    • Patient advocates
    • Work Packages
    • Monitoring
    • Publications Acknowledging ERN-RND
  • Expert Centres
    • … for rare neurological diseases
    • Full members and affiliated partners
    • How to contact expert centres
    • Supporting partners
    • Map of expert centers
    • Overview ERNs
  • Online case discussion with CPMS
    • What is the CPMS
    • Who can use it
    • How to use it
    • MLD Treatment eligibility panel
    • Neuroradiology Expert Advice Panel
    • Multidisciplinary Board for DBS in Dystonia
    • CPMS Helpdesk
    • Videos
    • Downloads
    • Websites
  • Disease Knowledge
    • Cerebellar Ataxia & Hereditary Spastic Paraplegias (HSPs)
    • Chorea & Huntington’s disease
    • Dystonias, NBIA and Paroxysmal Disorders
    • Frontotemporal dementia
    • Leukoencephalopathies
    • Atypical Parkinsonism: MSA, PSP & Genetic Parkinson’s Disease
    • ERN-RND Patient Journeys
  • Education & Training
    • Online Medical Education
    • Upcoming Webinars
    • Training Resources
    • Webinars from Partners
    • Winter School
  • ERN-RND Registry
    • ERN-RND registry objectives
    • Disease Groups covered
    • Data Submission
      • Data Analysis 2023
    • Data Access
    • Contact
  • Collab­ora­tions
    • Projects
    • Partner organisations
    • Past projects
      • EJP RD
        • EJP RD in a nutshell
        • What is EJP RD?
        • EJP RD mission & goals
        • EJP RD & ERNs
      • Solve-RD
        • What is Solve-RD?
        • Main Objectives
        • Implementation Steps
        • Analysis
      • Value of Treatment (VoT) project
        • VoT project coordinator
        • Objectives of the VoT project
        • ERN-RND in VoT2
        • Academic partners in VoT2
        • Further reading
  • News & Events
    • News
    • Events
    • Newsletter
    • Meet the members
  • Contact us
  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube

Domain: Diagnosis/Neurogenetics

The Importance of Genetic Counselling in the Diagnostic of Rare Neurological Disorders

The Importance of Genetic Counselling in the Diagnostic of Rare Neurological Disorders

09 December 2025 | 3 – 4 pm CET
Zoom Registration

Speaker: Maria Judit Molnar
Semmelweis University, Budapest, Hungary

The ERN-RND Diagnostic Flowcharts: A Clinical Algorithm for the Diagnosis of Ataxias and Hereditary Spastic Paraplegias

The ERN-RND Diagnostic Flowcharts: A Clinical Algorithm for the Diagnosis of Ataxias and Hereditary Spastic Paraplegias

25 Mar. 2025

Speaker: Elisabetta Indelicato & Enrico Bertini
Medical University Innsbruck, Austria;
Pediatric Hospital Bambino Gesù, Rome, Italy

Recording

Slides

Treatment of ataxia – genetics based

Treatment of ataxia – genetics based

Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025

Speaker: Ronald Buijsen
Leiden University, The Netherlands

Recording

Treatment of spasticity in children with rare neurological disorders – who, why, when and what?

Treatment of spasticity in children with rare neurological disorders – who, why, when and what?

Winter school 2025 “Challenges of treating rare neurological diseases”
13 Mar. 2025

Speaker: Annemieke Buizer
Amsterdam UMC, The Netherlands

Recording

Treatment of nano-rare neurological diseases

Treatment of nano-rare neurological diseases

Winter school 2025 “Challenges of treating rare neurological diseases”
12 Mar. 2025

Speaker: Marlen Lauffer
Leiden University Medical Center​, The Netherlands

Recording

Autonomic dysfunction in movement disorders

Autonomic dysfunction in movement disorders

19 Nov. 2024

Speaker: Pietro Guaraldi
Azienda USL di Bologna, IRCCS Institute of Neurological Sciences, Bologna, Italy

Recording

Diagnostic approach to childhood-onset chorea

Diagnostic approach to childhood-onset chorea

5 Nov. 2024

Speaker: Juan Darío Ortigoza-Escobar
Hospital Sant Joan de Déu, Barcelona, Spain

Recording

Clinical neurophysiology in dystonia

Clinical neurophysiology in dystonia

24 Sep. 2024

Speaker: Anke Snijders
Radboud University Medical Center, Netherlands

Recording

Autoimmune parkinsonism

Autoimmune parkinsonism

25 Jun. 2024

Speaker: Jeroen Kerstens
Antwerp University Hospital, Belgium

Recording

Neuroimaging for Implantation and Programming in Dystonia Patients

Neuroimaging for Implantation and Programming in Dystonia Patients

Winter school 2024 “DBS in dystonia”
17-19 Apr. 2024

Speaker: Martin Reich
Clinic

Recording

The spectrum of genetic synucleinopathies

The spectrum of genetic synucleinopathies

12 Mar. 2024

Speaker: Leonidas Stefanis
University of Athens Medical School, Athens, Greece

Recording

Neuropsychological assessment in primary progressive aphasia – recommendations and pitfalls in clinical practice

Neuropsychological assessment in primary progressive aphasia – recommendations and pitfalls in clinical practice

27 Feb. 2024

Speaker: Lize Jiskoot
Erasmus Medical Center Rotterdam, Netherlands

Recording

Newborn screening in leukodystrophies

Newborn screening in leukodystrophies

20 Feb. 2024

Speaker: Lucia Laugwitz
University Hospital Tübingen, Germany

Recording

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

6 Feb. 2024

Speaker: Sarah Tabrizi
UCL Queen Square Institute of Neurology, London, UK

Recording

Autoimmune Chorea

Autoimmune Chorea

23 Jan. 2024

Speaker: Jeroen Kerstens
Antwerp University Hospital, Belgium

Recording

Friedreich Ataxia

Friedreich Ataxia

12 Sep. 2023

Speaker: Kathrin Reetz
RWTH-University Hospital Aachen, Germany

Slides

Dissecting Fahr’s Disease

Dissecting Fahr’s Disease

13 Jun. 2023

Speaker: Amit Batla & Francesca Magrinelli
Institute of Neurology, University College London, UK

Recording

Slides

Frontotemporal dementia vs. primary psychiatric disorders

Frontotemporal dementia vs. primary psychiatric disorders

23 May 2023

Speaker: Tim van Langenhove
University Hospital Ghent, Belgium

Slides

Non-pharmacological approaches to treatment in svPPA

Non-pharmacological approaches to treatment in svPPA

9 May 2023

Speaker: Ana Sofia Costa
RWTH-University Hospital Aachen, Germany

Recording

FTD- in whom, when and how genetic testing should be applied

FTD- in whom, when and how genetic testing should be applied

14 Mar. 2023

Speaker: Laura Donker Kaat
Erasmus Medical Center Rotterdam, Netherlands

Recording

Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness

Use of Biomarkers to monitor the presymptomatic phase of Genetic FTD: research advances for clinical trial readiness

22 Nov. 2022

Speaker: Harro Seelaar & Dario Saracino
Erasmus University Medical Center, Rotterdam, Netherlands;
APHP – Pitié-Salpêtrière Hospital, Paris, France

Slides

VPS13A and XK bulk lipid transfer diseases (formerly the now obsolete Levine-Critchley syndrome)

VPS13A and XK bulk lipid transfer diseases (formerly the now obsolete Levine-Critchley syndrome)

25 Oct. 2022

Speaker: Adrian Danek
Ludwig Maximilian University Hospital, Munich, Germany

Recording

Slides

DBS in Dystonia – Targets, programming and therapeutic challenges

DBS in Dystonia – Targets, programming and therapeutic challenges

18 Oct. 2022

Speaker: Philipp Capetian
University Hospital Würzburg, Germany

Slides

Krabbe disease – natural history and treatment options

Krabbe disease – natural history and treatment options

11 Oct. 2022

Speaker: Samuel Gröschel & Ingeborg Krägeloh
University Hospital Tübingen, Germany

Recording

Slides

CACNA1A-related disorders: clinical presentation and therapeutic options

CACNA1A-related disorders: clinical presentation and therapeutic options

4 Oct. 2022

Speaker: Elisbetta Indelicato
Medical University Innsbruck, Austria

Slides

Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease

Clinical and genetic predictors of subthalamic nucleus deep brain stimulation in Parkinson’s disease

27 Sep. 2022

Speaker: Daniel Weiß
Hertie Institute for Clinical Brain Research, University of Tübingen, Germany

Recording

Tau-targeting Therapies: Where are we heading to?

Tau-targeting Therapies: Where are we heading to?

20 Sep. 2022

Speaker: Günter Höglinger
Medical Schhol Hannover, Germany

Recording

Vanishing white matter

Vanishing white matter

13 Sep. 2022

Speaker: Marjo van der Knaap
VU University Medical Center Amsterdam, Netherlands

Recording

Young onset Parkinson’s disease – What is the difference?

Young onset Parkinson’s disease – What is the difference?

5 Jul. 2022

Speaker: Bart Post
Radboud University Medical Centre, Nijmegen, Netherlands

Recording

Slides

Magnetic resonance imaging in the diagnostic assessment of cerebellar ataxias

Magnetic resonance imaging in the diagnostic assessment of cerebellar ataxias

28 Jun. 2022

Speaker: Jennifer Faber
German center for neurodegenerative disorders (DZNE), Bonn, Germany

Slides

Posts pagination

Page 1 Page 2 Page 3 Next page

Webinar Schedule

Find us on Bluesky

ERN-RND

@ern-rnd.bsky.social

168 Followers 90 Following 194 Posts

European Reference Network for Rare Neurological Diseases (ERN-RND) to improve diagnosis, care & treatment of RND patients.
Free webinars: https://www.ern-rnd.eu/education-training/online-medical-education-for-rare-neurological-diseases/

  • Get to this post

    ERN-RND @ern-rnd.bsky.social 3 days

    Stay informed: Whether you’re a clinician, patient, carer, or patient representative, our ERN-RND #newsletter is your go-to source for the latest updates on Rare Neurological Diseases in Europe: www.ern-rnd.eu?mailpoet_rou...

    #RareDisease #RareNeurologicalDisease #Neurology #RareNeurology
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 5 days

    💻 Upcoming #webinar on “Fluid Biomarkers in Frontotemporal Dementia”
    📅 2nd December, 3:00 CET
    🗣️ Domenico Plantone, AOU - University Hospital Siena, Italy

    Sign up 👉https://t1p.de/9hsbhttps://t1p.de/9hsbctps://bsky.app/hashtag/webinar">#webinar and
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 weeks

    💻#webinar on “Guidelines on the Assessment and Treatment of Neurogenic Urinary and Sexual Symptoms”
    📅25th November, 3 CET
    🗣️A. Fanciulli and P. Guaraldi, Medical University Innsbruck and Azienda USL di Bologna
    Sign up 👉 https://t1p.de/9chttps://t1p.de/9cxi7app/hashtag/webinar">#webinart with the and
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 weeks

    💻 Upcoming #webinar on “Recent Advances in Episodic Ataxias”
    📅 18th November, 3:00 CET
    🗣️ E. Indelicato and D. Pellerin, Medical University Innsbruck, Austria, and Miller School of Medicine, Miami, USA
    Sign up 👉 https://t1p.de/6uunhttps://t1p.de/6uunpps://bsky.app/hashtag/webinar">#webinar and
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 weeks

    Welcome everyone to Day 2 of our Annual Meeting 2025! We just started into our Disease Group meetings of today.
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 weeks

    #QuizNight: A great evening full of laughter, learning, and connection!
    How much do you know about ERN-RND?
    Do you know how many data sets were submitted to the ERN-RND registry in 2024?
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 weeks

    Patient advocate workshop guided by one key question: what needs our attention most in the RND community? Mental health support? Lack of knowledge and awareness? Tailored transitioning care in adolescence?
    Many inspiring ideas and discussions! We’re excited to see how they’ll shape future projects!

Find us on Facebook

ERN-RND European Reference Network for Rare Neurological Diseases

Our mission

ERN-RND aims to support rare neurological patients in Europe in getting a timely and appropriate diagnosis, treatment and care.

ERNs

ERN-RND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. For more information about the ERNs and the EU Health strategy, please visit https://ec.europa.eu/health/ern_en

  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube

Sitemap | Disclaimer and Data Protection

We serve cookies on this site to analyse traffic, remember your preferences, and optimise your experience.